AITL and ALCL (ALK + and −) subtypes presented with a staggering 100% ORR and with CRR of 61.9% and 100%, respectively (ALCL ALK+) [120]. The gene discussed is ALK; the disease is angioimmunoblastic T-cell lymphoma.